Remove Investment Banking Remove Medical Remove Private Equity
article thumbnail

Private Equity Interest in Orthopedics Grows

JD Supra: Mergers

Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. By: FOCUS Investment Banking But that’s been changing over the past few years and is likely to continue to grow moving forward.

article thumbnail

What is the Value of My Medical Practice?

JD Supra: Mergers

This article focuses on how medical practices are valued by private equity-backed groups, and to an extent, health systems and other strategic acquirers. By: FOCUS Investment Banking Please see full Article below for more information.

Medical 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Private Equity uses ‘Roll-up’ Strategies to Drive Investment Returns

OfficeHours

In the pursuit of attractive equity returns, private equity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of private equity-backed roll-up activity.

article thumbnail

How to Manage Risks When Selling Your Physician Practice

JD Supra: Mergers

Based on the large number of medical practices acquired over the past decade, you may think selling your practice is a routine process. By: FOCUS Investment Banking

article thumbnail

Private Equity Interest in Orthopedics Grows

Focus Investment Banking

Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. Despite the recent rash of M&A deals, the orthopedic business, like other medical fields, remains highly fragmented.

article thumbnail

ENT & Allergy Practices Attract Private Equity

Focus Investment Banking

Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—private equity firms have a lot of capital to put to work. ENT and allergy is relatively new to private equity investment, with approximately ten major platforms currently operating.

article thumbnail

Recap: 2023 Midwest M&A/Private Equity Forum

Focus Investment Banking

The 6th annual Midwest M&A/Private Equity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.